-
Mashup Score: 2Equity in Health Care Collection: CHEST - 26 day(s) ago
Vol. 164 Issue 6 p1359 – 1360 Vikramjit Mukherjee Ryan C. Maves We have endured a disaster on a scale that few could have anticipated in 2019. After a prolonged emergency with more than 1 million deaths in the United States alone, critical care professionals have become familiar with concepts of resource limitations, load-balancing, and triage. Although the acute phase of the COVID-19 pandemic hopefully is past us, disasters occur regularly. Natural disasters such as extreme weather events, wildfires,
Source: journal.chestnet.orgCategories: General Medicine News, PulmonologyTweet
-
Mashup Score: 3
Climate change represents a major and growing threat to population health and disproportionately affects patients with respiratory illness by driving increased symptoms, exacerbations, and health care use in both asthma and COPD.
Source: journal.chestnet.orgCategories: General Medicine News, PulmonologyTweet
-
Mashup Score: 5Precision Solutions - 29 day(s) ago
Pulmonary hypertension (PH) is a life-threatening condition characterized by abnormally elevated pulmonary pressures and progressive right-sided heart failure.1 Current therapies can improve quality of life and reduce morbidity and mortality; however, lung transplantation remains the only option for end-stage disease because of the progressive nature of PH. One of the key priorities in PH care is early diagnosis, risk stratification, and treatment initiation of patients receiving care at regional medical centers.
Source: journal.chestnet.orgCategories: General Medicine News, PulmonologyTweet-
Survey results assessing the state of pulmonary hypertension in Latin America show the need for prompt action by health care professional organizations and each country’s health system. Read more in the latest #CHESTHumanities article in the March issue: https://t.co/reQ4SBbVgY https://t.co/hiUThPpOYf
-
-
Mashup Score: 9Exertional Desaturation During the 6-Minute Walk Test vs Daily Life in People With Fibrotic Interstitial Lung Disease - 29 day(s) ago
Fibrotic interstitial lung disease (fILD) is characterized by fibrosis of the lung tissue that often progresses over time.1 Exertional desaturation is a common feature of fILD2 that often is treated with ambulatory oxygen therapy (AOT).3 The 6-min walk test (6MWT) is used commonly to identify the presence and extent of exertional desaturation and consequently guides prescription of AOT. It is unclear whether the 6MWT accurately detects desaturation during daily life in people with fILD.4 The primary aim of this study was to assess the relationship between exertional desaturation during the 6MWT and during daily life in people with fILD.
Source: journal.chestnet.orgCategories: General Medicine News, PulmonologyTweet
-
Mashup Score: 45A Diagnostic Approach to Fungal Pneumonia - 1 month(s) ago
Although bacteria significantly exceed fungi as the most common cause of lower respiratory tract infection, the incidence of fungal pneumonia is increasing because of a growing at-risk population of immunocompromised individuals as well as anthropogenic global heating and environmental disruption. When a patient presents with a clinical syndrome of pneumonia, a constellation of factors must be considered to determine the probability of a fungal pneumonia, including host factors, epidemiologic exposures, suggestive radiographic patterns, and the presence of a non-resolving pneumonia.
Source: journal.chestnet.orgCategories: General Medicine News, PulmonologyTweet
-
Mashup Score: 6
Pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with left-sided heart and lung diseases are most commonly easily discriminated and treated accordingly. With the changing epidemiology of PAH, however, a growing proportion of patients at the time of diagnosis present with comorbidities of varying severity. In addition to classical PAH, two distinct phenotypes have emerged: a heart failure with preserved ejection fraction-like phenotype and a lung phenotype. Importantly, the evidence supporting the currently proposed treatment algorithm for PAH has been generated mainly from PAH trials in which patients with cardiopulmonary comorbidities have been underrepresented or excluded.
Source: journal.chestnet.orgCategories: General Medicine News, PulmonologyTweet
-
Mashup Score: 88Misuses of “Quality of Life” Judgments in End-of-Life Care - 1 month(s) ago
Physicians’ misperceptions about their disabled patients’ quality of life (QoL) can influence their decision to offer certain medical treatments. There are at least three domains in which misconceptions about a disabled QoL might result in unequal care for disabled patients and could even lead to a patient’s untimely death: (1) futility declarations, (2) recommendations for comfort care, (3) and the distribution of scarce resources. This article argues that medical futility decisions should not be based on a physician’s QoL judgments, that physicians should not steer disabled patients into comfort care when they have treatable illnesses, and that disability alone should never be a reason to deprioritize a patient for scarce medical resources.
Source: journal.chestnet.orgCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 30
Pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with left-sided heart and lung diseases are most commonly easily discriminated and treated accordingly. With the changing epidemiology of PAH, however, a growing proportion of patients at the time of diagnosis present with comorbidities of varying severity. In addition to classical PAH, two distinct phenotypes have emerged: a heart failure with preserved ejection fraction-like phenotype and a lung phenotype. Importantly, the evidence supporting the currently proposed treatment algorithm for PAH has been generated mainly from PAH trials in which patients with cardiopulmonary comorbidities have been underrepresented or excluded.
Source: journal.chestnet.orgCategories: General Medicine News, PulmonologyTweet
-
Mashup Score: 9
Climate change represents a major and growing threat to population health and disproportionately affects patients with respiratory illness by driving increased symptoms, exacerbations, and health care use in both asthma and COPD.
Source: journal.chestnet.orgCategories: General Medicine News, PulmonologyTweet
-
Mashup Score: 0Precision Solutions - 1 month(s) ago
Pulmonary hypertension (PH) is a life-threatening condition characterized by abnormally elevated pulmonary pressures and progressive right-sided heart failure.1 Current therapies can improve quality of life and reduce morbidity and mortality; however, lung transplantation remains the only option for end-stage disease because of the progressive nature of PH. One of the key priorities in PH care is early diagnosis, risk stratification, and treatment initiation of patients receiving care at regional medical centers.
Source: journal.chestnet.orgCategories: General Medicine News, PulmonologyTweet-
Survey results assessing the state of pulmonary hypertension in Latin America show the need for prompt action by health care professional organizations and each country’s health system. Read the #CHESTHumanities article in the March @journal_CHEST issue: https://t.co/hnv8nUB1eq https://t.co/e8zLmHdjHQ
-
April is #MinorityHealthMonth. Visit the Equity Topic Collection curated by @journal_CHEST to read the latest research: https://t.co/LtZ5PvmUGE #MedEd #HealthEquity https://t.co/9WyC99tDax